TSC2: filling the GAP in the mTOR signaling pathway.
暂无分享,去创建一个
K. Inoki | K. Guan | M. Corradetti | Yong Li
[1] R. Yeung. Multiple roles of the tuberous sclerosis complex genes , 2003, Genes, chromosomes & cancer.
[2] F. Tamanoi,et al. Identification of Dominant Negative Mutants of Rheb GTPase and Their Use to Implicate the Involvement of Human Rheb in the Activation of p70S6K* , 2003, Journal of Biological Chemistry.
[3] F. Tamanoi,et al. Drosophila Rheb GTPase is required for cell cycle progression and cell growth , 2003, Journal of Cell Science.
[4] A. F. Castro,et al. Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner* , 2003, Journal of Biological Chemistry.
[5] J. Blenis,et al. Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.
[6] K. Inoki,et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.
[7] S. Schreiber,et al. Integration of growth factor and nutrient signaling: implications for cancer biology. , 2003, Molecular cell.
[8] V. Krymskaya. Tumour suppressors hamartin and tuberin: intracellular signalling. , 2003, Cellular signalling.
[9] E. Hafen,et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.
[10] E. Hafen,et al. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila , 2003, Nature Cell Biology.
[11] B. Edgar,et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.
[12] B. Edgar,et al. Rheb promotes cell growth as a component of the insulin/TOR signalling network , 2003, Nature Cell Biology.
[13] M. Goedbloed,et al. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins. , 2003, Biochemical Society transactions.
[14] K. Inoki,et al. The p38 and MK2 Kinase Cascade Phosphorylates Tuberin, the Tuberous Sclerosis 2 Gene Product, and Enhances Its Interaction with 14-3-3* , 2003, The Journal of Biological Chemistry.
[15] Paul Tempst,et al. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. , 2003, Molecular cell.
[16] Y. Xiong,et al. 14-3-3β Binds to and Negatively Regulates the Tuberous Sclerosis Complex 2 (TSC2) Tumor Suppressor Gene Product, Tuberin* , 2003, The Journal of Biological Chemistry.
[17] D. Kwiatkowski,et al. Tuberous Sclerosis: from Tubers to mTOR , 2003, Annals of human genetics.
[18] E. Henske,et al. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration , 2002, Oncogene.
[19] Hongbing Zhang,et al. Tsc2 Null Murine Neuroepithelial Cells Are a Model for Human Tuber Giant Cells, and Show Activation of an mTOR Pathway , 2002, Molecular and Cellular Neuroscience.
[20] K. Inoki,et al. Regulation of TSC2 by 14-3-3 Binding* , 2002, The Journal of Biological Chemistry.
[21] Steven J. Marygold,et al. Growth Signaling: TSC Takes Its Place , 2002, Current Biology.
[22] Y. Nabeshima,et al. Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system. , 2002, Human Molecular Genetics.
[23] C. Walker,et al. 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). , 2002, Cancer research.
[24] C. Proud,et al. Regulation of mammalian translation factors by nutrients. , 2002, European journal of biochemistry.
[25] A. Hodges,et al. Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent , 2002, The Journal of cell biology.
[26] L. Aicher,et al. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. , 2002, Cancer research.
[27] R. Abraham. Identification of TOR Signaling Complexes More TORC for the Cell Growth Engine , 2002, Cell.
[28] David J. Kwiatkowski,et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Nicosia,et al. Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.
[30] P. Worley,et al. Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells , 2002, Oncogene.
[31] O. Hino,et al. Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling , 2002, Nature Cell Biology.
[32] D. Alessi,et al. TSC1–TSC2: a complex tale of PKB-mediated S6K regulation , 2002, Nature Cell Biology.
[33] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[34] D. Kwiatkowski,et al. Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation , 2002, The Journal of Biological Chemistry.
[35] Channing J Der,et al. Farnesyltransferase inhibitors: promises and realities. , 2002, Current opinion in pharmacology.
[36] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[37] A. Hall,et al. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. , 2002, Genes & development.
[38] Tomohiro Matsumoto,et al. Role of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast Schizosaccharomyces pombe. , 2002, Genetics.
[39] J. Blenis,et al. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.
[40] Gideon Bollag,et al. GTPase activating proteins: critical regulators of intracellular signaling. , 2002, Biochimica et biophysica acta.
[41] Hongbing Zhang,et al. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.
[42] A. V. D. van den Ouweland,et al. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. , 2001, Human molecular genetics.
[43] A. Hodges,et al. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. , 2001, Human molecular genetics.
[44] J. Urano,et al. Failure to farnesylate Rheb protein contributes to the enrichment of G0/G1 phase cells in the Schizosaccharomyces pombe farnesyltransferase mutant , 2001, Molecular microbiology.
[45] Tetsuo Noda,et al. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Hengstschläger,et al. Tuberous sclerosis gene products in proliferation control. , 2001, Mutation research.
[47] Xinsheng Gao,et al. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. , 2001, Genes & development.
[48] C. Potter,et al. Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size , 2001, Cell.
[49] B. Dickson,et al. The Drosophila Tuberous Sclerosis Complex Gene Homologs Restrict Cell Growth and Cell Proliferation , 2001, Cell.
[50] G. Landes,et al. Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. , 2001, Molecular cell.
[51] J. Heitman,et al. The TOR Kinases Link Nutrient Sensing to Cell Growth* , 2001, The Journal of Biological Chemistry.
[52] G. Rubin,et al. gigas , a Drosophila Homolog of Tuberous Sclerosis Gene Product-2, Regulates the Cell Cycle , 1999, Cell.
[53] J. Urano,et al. Characterization of Rheb functions using yeast and mammalian systems. , 2001, Methods in enzymology.
[54] J Otlewski,et al. Structure of small G proteins and their regulators. , 2001, Acta biochimica Polonica.
[55] G. Benvenuto,et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination , 2000, Oncogene.
[56] Tobias Schmelzle,et al. TOR, a Central Controller of Cell Growth , 2000, Cell.
[57] D. Kwiatkowski,et al. Molecular genetic advances in tuberous sclerosis , 2000, Human Genetics.
[58] K. Furge,et al. Loss of Rhb1, a Rheb-related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvation. , 2000, Genetics.
[59] H. Vinters,et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho , 2000, Nature Cell Biology.
[60] H. Moses,et al. Farnesyltransferase Inhibitor Induces Rapid Growth Arrest and Blocks p70s6k Activation by Multiple Stimuli* , 2000, The Journal of Biological Chemistry.
[61] S. Sparagana,et al. Tuberous sclerosis complex. , 2000, Current opinion in neurology.
[62] G. Thomas,et al. Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.
[63] J. Cherfils,et al. GEFs: structural basis for their activation of small GTP-binding proteins. , 1999, Trends in biochemical sciences.
[64] S. Snyder,et al. Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. , 1999, Science.
[65] S Povey,et al. The genetic basis of tuberous sclerosis. , 1998, Molecular medicine today.
[66] A. Wittinghofer,et al. GTPase-activating proteins: helping hands to complement an active site. , 1998, Trends in biochemical sciences.
[67] R. Snell,et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.
[68] P. Harris,et al. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. , 1997, Human molecular genetics.
[69] W. Kabsch,et al. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.
[70] C. Der,et al. The Ras-related Protein Rheb Is Farnesylated and Antagonizes Ras Signaling and Transformation* , 1997, The Journal of Biological Chemistry.
[71] E. Golemis,et al. The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.
[72] P. Worley,et al. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals , 1997, Molecular and cellular biology.
[73] P. Casey,et al. Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.
[74] R. Sandford,et al. Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. , 1996, Human molecular genetics.
[75] J. Declue,et al. Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.
[76] C. Barnes,et al. rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. , 1994, The Journal of biological chemistry.
[77] K. Kaibuchi,et al. Small GTP-binding proteins. , 1992, International review of cytology.